Liu Yuqi, Chen Yundai
Cardiac Department, Chinese PLA General Hospital, Medical School of Chinese PLA, Beijing, China.
Department of Cardiology & National Clinical Research Center of Geriatrics Disease, Chinese PLA General Hospital, Beijing, China.
Front Cell Dev Biol. 2021 Jan 22;8:634137. doi: 10.3389/fcell.2020.634137. eCollection 2020.
Essential hypertension (EH) is one of the most common cardiovascular diseases worldwide, entailing a high level of morbidity. EH is a multifactorial disease influenced by both genetic and environmental factors, including mitochondrial DNA (mtDNA) genotype. Previous studies identified mtDNA mutations that are associated with maternally inherited hypertension, including tRNA m.4263A>G, m.4291T>C, m.4295A>G, tRNA m.4435A>G, tRNA m.5655A>G, and tRNA/tRNA m.4401A>G, et al. These mtDNA mutations alter tRNA structure, thereby leading to metabolic disorders. Metabolic defects associated with mitochondrial tRNAs affect protein synthesis, cause oxidative phosphorylation defects, reduced ATP synthesis, and increase production of reactive oxygen species. In this review we discuss known mutations of tRNA genes encoded by mtDNA and the potential mechanisms by which these mutations may contribute to hypertension.
原发性高血压(EH)是全球最常见的心血管疾病之一,发病率很高。EH是一种受遗传和环境因素(包括线粒体DNA(mtDNA)基因型)影响的多因素疾病。先前的研究确定了与母系遗传高血压相关的mtDNA突变,包括tRNA m.4263A>G、m.4291T>C、m.4295A>G、tRNA m.4435A>G、tRNA m.5655A>G以及tRNA/tRNA m.4401A>G等。这些mtDNA突变改变了tRNA结构,从而导致代谢紊乱。与线粒体tRNA相关的代谢缺陷会影响蛋白质合成,导致氧化磷酸化缺陷、ATP合成减少,并增加活性氧的产生。在本综述中,我们讨论了由mtDNA编码的tRNA基因的已知突变以及这些突变可能导致高血压的潜在机制。